You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

28 March 2018

New research explores the reasons men stop taking PrEP

Research reveals that most gay and bisexual men who stop taking pre-exposure prophylaxis (PrEP) in the USA do so because it is too expensive or they see themselves as no longer having a need for it.  

0
06 June 2017

Grindr survey reveals many gay men using PrEP without doctor support

There is a high appetite for increased access to pre-exposure prophylaxis (PrEP) among gay app users in Switzerland, according to research looking into the need for a national PrEP programme.

0
26 April 2017

Doctors in the USA see few cases of risk compensation among PrEP users

Most healthcare providers cite worries over risk compensation after providing PrEP, but experiences among doctors who do prescribe PrEP are positive.

0
14 November 2016

Norway provides PrEP for free to all those at risk of HIV

The game-changing drug, Truvada – the only drug approved for PrEP – will be offered to groups considered at risk of HIV.

0
14 September 2016

Europe grants marketing approval of Truvada for use as PrEP

The European Commission has given pharmaceutical company, Gilead, the green light to market Truvada as pre-exposure prophylaxis (PrEP) across the region.

0
23 March 2016

Advocates left shocked by NHS England decision against providing PrEP

National Health Service (NHS) England has decided against providing pre-exposure prophylaxis (PrEP) for HIV-negative people at a high risk of HIV, sparking outrage among a number of HIV charities and service providers in the UK.

0